Impact
BioMedical SIG #3
Join Katrina Bradley and BioMedical SIG for a webinar on market access strategies in life sciences. Learn to plan, execute, and optimise early tech deployment.
Search for resources
Impact
BioMedical SIG #2
Second webinar of the series, From research and innovation to development: how to plan and execute translational projects in life sciences. This webinar will focus on the process involved with the release of new medical devices.
Impact
BioMedical SIG #1
First webinar of the series, From research and innovation to development: how to plan and execute translational projects in life sciences, From bench to bedside focuses on the process of creating new medicines. Matthias Versele, Executive Director Drug Discovery from Cistim, Belgium, presents CD3-Cistim’s strategy for the evaluation and execution of drug development projects.
Journals and Articles
Innovation in water-related technologies
This EPO study gives insights into trends in innovation in water-related technologies aimed at both the provision of and protection from water.
Impact
Digital Innovations SIG: World Lunch #6
With Laura Spinardi, Head of Technology Transfer Office, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, we discussed the challenges of managing data in digital clinical research: not just the privacy/personal data issues, but also data management and data sharing within collaborative research projects, using data for machine learning and training, and the ease or difficulty of transferring data in licensing and spin out opportunities.
Impact
Digital Innovations SIG: World Lunch #5
Michiel Hulsbergen is CEO and founder of DialogueTrainer. In this edition of the Digital Innovation SIG World Lunch, Michiel shared the challenges he has faced setting up and running the company. As a spin-out from the Utrecht University, how did he navigate the issues of IP, funding and commercial development?
Toolbox
Doing Business in the United States
Biotechnology and genetics research have been the subject of extensive investment by both the public and private sectors, with the resulting products and processes making a significant and increasing contribution to human health and health care.
Impact
Tea with ASTP: Negotiating Licensing Terms
In this webinar recording, Anja Zimmerman, discusses how knowledge and technology transfer can happen in numerous ways, from publication of research results to collaborations between scientist, between research organisations, between academia and industry or by creating companies.
Training Materials
Drafting and Negotiating Clinical Trial Agreements
Toolbox
Guidelines: Licensing genetic inventions
Biotechnology and genetics research have been the subject of extensive investment by both the public and private sectors, with the resulting products and processes making a significant and increasing contribution to human health and health care.